1. Home
  2. HYPR vs SER Comparison

HYPR vs SER Comparison

Compare HYPR & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HYPR
  • SER
  • Stock Information
  • Founded
  • HYPR 2014
  • SER 2017
  • Country
  • HYPR United States
  • SER United States
  • Employees
  • HYPR N/A
  • SER N/A
  • Industry
  • HYPR Medical Specialities
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • HYPR Health Care
  • SER Health Care
  • Exchange
  • HYPR Nasdaq
  • SER Nasdaq
  • Market Cap
  • HYPR 55.9M
  • SER 56.5M
  • IPO Year
  • HYPR N/A
  • SER 2018
  • Fundamental
  • Price
  • HYPR $1.02
  • SER $5.45
  • Analyst Decision
  • HYPR Strong Buy
  • SER Strong Buy
  • Analyst Count
  • HYPR 3
  • SER 2
  • Target Price
  • HYPR $1.06
  • SER $13.00
  • AVG Volume (30 Days)
  • HYPR 487.2K
  • SER 34.0K
  • Earning Date
  • HYPR 08-07-2025
  • SER 08-08-2025
  • Dividend Yield
  • HYPR N/A
  • SER N/A
  • EPS Growth
  • HYPR N/A
  • SER N/A
  • EPS
  • HYPR N/A
  • SER N/A
  • Revenue
  • HYPR $11,732,000.00
  • SER $51,000.00
  • Revenue This Year
  • HYPR $12.31
  • SER N/A
  • Revenue Next Year
  • HYPR $29.29
  • SER N/A
  • P/E Ratio
  • HYPR N/A
  • SER N/A
  • Revenue Growth
  • HYPR 0.34
  • SER N/A
  • 52 Week Low
  • HYPR $0.53
  • SER $3.81
  • 52 Week High
  • HYPR $1.90
  • SER $11.14
  • Technical
  • Relative Strength Index (RSI)
  • HYPR 59.21
  • SER 46.90
  • Support Level
  • HYPR $1.00
  • SER $5.11
  • Resistance Level
  • HYPR $1.20
  • SER $6.50
  • Average True Range (ATR)
  • HYPR 0.10
  • SER 0.43
  • MACD
  • HYPR 0.01
  • SER 0.03
  • Stochastic Oscillator
  • HYPR 59.09
  • SER 33.12

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: